Literature DB >> 26617355

The Microbiology of Hidradenitis Suppurativa.

Hans Christian Ring1, Lennart Emtestam2.   

Abstract

Although the clinical presentation of Hidradenitis Suppurativa (HS) is strongly reminiscent of bacterial infection, the role of bacteria remains controversial. Studies have isolated an array of different bacterial specimens as well as biofilm formation in lesional HS skin. Consistent findings of Gram-positive cocci and -rods including Staphylococus aureus, Coagulase-negative staphylococci (CoNS) and Corynebacterium species (spp) in deep tissue samples have been demonstrated in HS. Although efficacy of antibiotics, i.e., rifampicin, clindamycin or tetracycline may support a microbial role in disease pathogenesis, the most often isolated bacterial specimens are commensal bacteria (CoNS).
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acne inversa; Bacteria; Colonization; Hidradenitis suppurativa; Microbiology

Mesh:

Substances:

Year:  2016        PMID: 26617355     DOI: 10.1016/j.det.2015.08.010

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  7 in total

Review 1.  North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management.

Authors:  Ali Alikhan; Christopher Sayed; Afsaneh Alavi; Raed Alhusayen; Alain Brassard; Craig Burkhart; Karen Crowell; Daniel B Eisen; Alice B Gottlieb; Iltefat Hamzavi; Paul G Hazen; Tara Jaleel; Alexa B Kimball; Joslyn Kirby; Michelle A Lowes; Robert Micheletti; Angela Miller; Haley B Naik; Dennis Orgill; Yves Poulin
Journal:  J Am Acad Dermatol       Date:  2019-03-11       Impact factor: 15.487

Review 2.  Review of Current Immunologic Therapies for Hidradenitis Suppurativa.

Authors:  Victoria K Shanmugam; Nadia Meher Zaman; Sean McNish; Faye N Hant
Journal:  Int J Rheumatol       Date:  2017-08-20

3.  A cross-sectional epidemiological study of hidradenitis suppurativa in an Irish population (SHIP).

Authors:  E Delany; G Gormley; R Hughes; S McCarthy; S Kirthi; T Markham; A-M Tobin; M Murphy; B Kirby
Journal:  J Eur Acad Dermatol Venereol       Date:  2017-12-06       Impact factor: 6.166

Review 4.  Hidradenitis suppurativa: an update on connecting the tracts.

Authors:  Mallory K Smith; Cynthia L Nicholson; Angela Parks-Miller; Iltefat H Hamzavi
Journal:  F1000Res       Date:  2017-07-28

5.  Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trials.

Authors:  G B E Jemec; M M Okun; S B Forman; W P F Gulliver; E P Prens; U Mrowietz; A W Armstrong; Z Geng; Y Gu; D A Williams; H D Teixeira; A B Kimball
Journal:  Br J Dermatol       Date:  2019-08-14       Impact factor: 9.302

Review 6.  Efficacy and Toxicity of Classical Immunosuppressants, Retinoids and Biologics in Hidradenitis Suppurativa.

Authors:  Kinnor Das; Steven Daveluy; George Kroumpouzos; Komal Agarwal; Indrashis Podder; Katherine Farnbach; Alex G Ortega-Loayza; Jacek C Szepietowski; Stephan Grabbe; Mohamad Goldust
Journal:  J Clin Med       Date:  2022-01-27       Impact factor: 4.241

7.  Virulence Gene Expression of Staphylococcus aureus in Human Skin.

Authors:  Ana Rita Cruz; Jos A G van Strijp; Fabio Bagnoli; Andrea G O Manetti
Journal:  Front Microbiol       Date:  2021-06-11       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.